Immuno-Chemotherapy as Single Treatment Modality for Larynx Preservation (ICoLP)
Latest Information Update: 21 Mar 2025
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Pembrolizumab (Primary) ; Carboplatin
- Indications Laryngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 18 Mar 2025 Planned End Date changed from 1 Mar 2025 to 1 Nov 2025.
- 18 Mar 2025 Planned primary completion date changed from 1 Mar 2025 to 1 Nov 2025.
- 11 Jan 2024 Planned End Date changed from 31 Jan 2025 to 1 Mar 2025.